MYLK and asthma: Pathways, such as cAMP signalling that mediate bronchorelaxation, for example cAMP dependent PKA inhibits MLCK by reducing its affinity for Ca2+/CaM (reviewed in [27]), may also be differentially regulated in ASM from subjects with asthma versus health.